450 related articles for article (PubMed ID: 28674049)
21. Pharmacokinetics, Pharmacodynamics, and Tolerability of Single-Dose Oral LCB01-0371, a Novel Oxazolidinone with Broad-Spectrum Activity, in Healthy Volunteers.
Cho YS; Lim HS; Lee SH; Cho YL; Nam HS; Bae KS
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712654
[TBL] [Abstract][Full Text] [Related]
22.
Kim DH; Kim SY; Koh WJ; Jhun BW
Antimicrob Agents Chemother; 2021 Jun; 65(7):e0230620. PubMed ID: 33903101
[TBL] [Abstract][Full Text] [Related]
23. Mycobacteriological characteristics and treatment outcomes in extrapulmonary Mycobacterium abscessus complex infections.
Jeong SH; Kim SY; Huh HJ; Ki CS; Lee NY; Kang CI; Chung DR; Peck KR; Shin SJ; Koh WJ
Int J Infect Dis; 2017 Jul; 60():49-56. PubMed ID: 28522316
[TBL] [Abstract][Full Text] [Related]
24. In Vitro Efficacy of Free and Nanoparticle Formulations of Gallium(III) meso-Tetraphenylporphyrine against Mycobacterium avium and Mycobacterium abscessus and Gallium Biodistribution in Mice.
Choi SR; Britigan BE; Switzer B; Hoke T; Moran D; Narayanasamy P
Mol Pharm; 2018 Mar; 15(3):1215-1225. PubMed ID: 29421865
[TBL] [Abstract][Full Text] [Related]
25. Activity of Oritavancin and Its Synergy with Other Antibiotics against
Wang G; Tang J; Feng J; Dong W; Huo X; Lu H; Wang C; Lu W; Wang X; Chen H; Tan C
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34198513
[TBL] [Abstract][Full Text] [Related]
26. Arabinosyltransferase C Mediates Multiple Drugs Intrinsic Resistance by Altering Cell Envelope Permeability in Mycobacterium abscessus.
Wang S; Cai X; Yu W; Zeng S; Zhang J; Guo L; Gao Y; Lu Z; Hameed HMA; Fang C; Tian X; Yusuf B; Chhotaray C; Alam MDS; Zhang B; Ge H; Maslov DA; Cook GM; Peng J; Lin Y; Zhong N; Zhang G; Zhang T
Microbiol Spectr; 2022 Aug; 10(4):e0276321. PubMed ID: 35946941
[TBL] [Abstract][Full Text] [Related]
27. Characterization of
Negatu DA; Aragaw WW; Dartois V; Dick T
Microbiol Spectr; 2023 Aug; 11(4):e0219923. PubMed ID: 37458588
[TBL] [Abstract][Full Text] [Related]
28. Drug susceptibility patterns of Mycobacterium abscessus and Mycobacterium massiliense isolated from respiratory specimens.
Cho EH; Huh HJ; Song DJ; Lee SH; Kim CK; Shin SY; Ki CS; Jhun BW; Moon SM; Kwon OJ; Koh WJ; Lee NY
Diagn Microbiol Infect Dis; 2019 Feb; 93(2):107-111. PubMed ID: 30236529
[TBL] [Abstract][Full Text] [Related]
29. Discrepancies between the genotypes and phenotypes of clarithromycin-resistant
Yoshida S; Tsuyuguchi K; Kobayashi T; Tomita M; Inoue Y; Hayashi S; Suzuki K
Int J Tuberc Lung Dis; 2018 Apr; 22(4):413-418. PubMed ID: 29562989
[TBL] [Abstract][Full Text] [Related]
30. Assessment of Clofazimine and TB47 Combination Activity against Mycobacterium abscessus Using a Bioluminescent Approach.
Liu Y; Tan Y; Islam MM; Cao Y; Lu X; Zeng S; Hameed HMA; Zhou P; Cai X; Wang S; Mugweru JN; Zhang G; Yin H; Liu J; Nuermberger E; Zhang T
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31843996
[No Abstract] [Full Text] [Related]
31. Bedaquiline Inhibits the ATP Synthase in Mycobacterium abscessus and Is Effective in Infected Zebrafish.
Dupont C; Viljoen A; Thomas S; Roquet-Banères F; Herrmann JL; Pethe K; Kremer L
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807917
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the intracellular activity of drugs against Mycobacterium abscessus using a THP-1 macrophage model.
Molina-Torres CA; Tamez-Peña L; Castro-Garza J; Ocampo-Candiani J; Vera-Cabrera L
J Microbiol Methods; 2018 May; 148():29-32. PubMed ID: 29626567
[TBL] [Abstract][Full Text] [Related]
33. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
Heidarieh P; Mirsaeidi M; Hashemzadeh M; Feizabadi MM; Bostanabad SZ; Nobar MG; Hashemi Shahraki A
Microb Drug Resist; 2016 Mar; 22(2):172-8. PubMed ID: 26468990
[TBL] [Abstract][Full Text] [Related]
34. Rifabutin Acts in Synergy and Is Bactericidal with Frontline Mycobacterium abscessus Antibiotics Clarithromycin and Tigecycline, Suggesting a Potent Treatment Combination.
Pryjma M; Burian J; Thompson CJ
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29760147
[No Abstract] [Full Text] [Related]
35.
Shen Y; Wang X; Jin J; Wu J; Zhang X; Chen J; Zhang W
Biomed Res Int; 2018; 2018():4902941. PubMed ID: 30687747
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary Mycobacterium abscessus Subspecies abscessus Disease That Showed a Discrepancy Between the Genotype and Phenotype of Clarithromycin Resistance.
Yamaba Y; Takakuwa O; Saito M; Kawae D; Yoshihara M; Mori Y; Kunii E; Ito Y; Yoshida S; Akita K
Intern Med; 2019 Sep; 58(18):2675-2678. PubMed ID: 31178483
[TBL] [Abstract][Full Text] [Related]
37. Determination of MIC Distribution and Mechanisms of Decreased Susceptibility to Bedaquiline among Clinical Isolates of Mycobacterium abscessus.
Li B; Ye M; Guo Q; Zhang Z; Yang S; Ma W; Yu F; Chu H
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712658
[TBL] [Abstract][Full Text] [Related]
38. Improved Performance Predicting Clarithromycin Resistance in
Lipworth S; Hough N; Buchanan R; Smith EG; Robinson E; Alexander E; Peto T; Crook D; Walker T
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31160290
[No Abstract] [Full Text] [Related]
39. Mycobacterium abscessus Associated Peritonitis with CAPD Successfully Treated Using a Linezolid and Tedizolid Containing Regimen Suggested Immunomodulatory Effects.
Seki M; Kamioka Y; Takano K; Imai H; Shoji M; Hariu M; Kabutoya Y; Watanabe Y
Am J Case Rep; 2020 Jun; 21():e924642. PubMed ID: 32598338
[TBL] [Abstract][Full Text] [Related]
40. Association between sequevar and antibiotic treatment outcome in patients with Mycobacterium abscessus complex infections in Japan.
Yoshida S; Tsuyuguchi K; Kobayashi T; Tomita M; Inoue Y; Hayashi S; Suzuki K
J Med Microbiol; 2018 Jan; 67(1):74-82. PubMed ID: 29227218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
